Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2013
12/12/2013WO2013182170A1 Enhancement of dissolution rate from pharmaceutical composition comprising bazedoxifene acetate
12/12/2013WO2013182070A1 Drug for preventing or treating mycobacterial diseases
12/12/2013WO2013181934A1 Polypeptide with function of synergistic targeted diagnosis and therapy of nasopharyngeal carcinoma, nanoparticles carrying same and use thereof
12/12/2013WO2013181840A1 Heterocyclic group contained amino-methanol derivative, and salt, synthetic method and use thereof
12/12/2013WO2013181786A1 Labdane diterpenoid compounds, semen biotae extract, and preparation method and use thereof
12/12/2013WO2013181742A1 Methods of inhibiting rsk for treatment of breast cancer
12/12/2013WO2013181731A1 Composition and methods for the production of biopolymeric materials that biodegrade rapidly, and are flexible and rigid, with use of the xanthan bioplastic as a component of the biopolymetric matrix and optionally fillers and/or nanofillers and other constituents, the resulting products and the uses thereof
12/12/2013WO2013181691A1 A method of treatment and compositions useful therefor, screening and prognostic agents and uses therefor
12/12/2013WO2013158970A3 Aminosteroids for the treatment of a ptp1b associated disease
12/12/2013WO2013158928A3 Chemosensory receptor ligand-based therapies
12/12/2013WO2013158698A3 Method treating scleroderma
12/12/2013WO2013158680A3 Compositions and methods comprising celecoxib or related compounds and dextromethorphan
12/12/2013WO2013158643A3 Remelted ingestible products
12/12/2013WO2013153553A3 Compositions for controlling varroa mites in bees
12/12/2013WO2013144977A3 An improved process for the preparation of etoricoxib
12/12/2013WO2013121449A8 Compositions and methods for the modulation of specific amidases for n-acylethanolamines for use in the therapy of inflammatory diseases
12/12/2013WO2013043998A3 Surgical barrier possessing clinically important absorption characteristics
12/12/2013WO2013031239A8 Novel mangromicin compound and production method therefor
12/12/2013WO2012170889A9 Cleavable lipids
12/12/2013WO2012148930A8 Oxidative retinal diseases
12/12/2013WO2012148926A8 Neurodegenerative disorders and muscle diseases implicating pufas
12/12/2013US20130333059 Hox compositions and methods
12/12/2013US20130331803 Transdermal therapeutic system comprising buprenorphine
12/12/2013US20130331738 Compositions and methods for potentiating sonothrombolysis
12/12/2013US20130331568 Acetylene derivatives having mglur 5 antagonistic activity
12/12/2013US20130331564 Epothilone derivatives
12/12/2013US20130331460 Chrysophaentin analogs that inhibit ftsz protein
12/12/2013US20130331458 Kit of ophthalmic composition
12/12/2013US20130331457 Treatment of cancer
12/12/2013US20130331453 4-(phenoxyalkyl)thio)-phenoxyacetic acids and analogs
12/12/2013US20130331452 Benzoic acid compounds for reducing uric acid
12/12/2013US20130331451 High Concentration Baclofen Preparations
12/12/2013US20130331449 Supplement composition and method of use to treat anhidrosis
12/12/2013US20130331447 Methods of treating hypertriglyceridemia
12/12/2013US20130331446 3-acyl-ingenols ii
12/12/2013US20130331445 Picropodophyllin Monohydrate or Polymorph A in Cancer Therapy
12/12/2013US20130331444 Treatment of cognitive disorders associated with abnormal dendritic spines using pkc activators
12/12/2013US20130331442 Combination Therapy for Cancer
12/12/2013US20130331440 Ucp1 (thermogenin) - inducing agents for use in the treatment of a disorder of the energy homeostasis
12/12/2013US20130331439 Methods for Diagnosing Stomach Cancer Using MicroRNAs
12/12/2013US20130331432 Metabolic gene, enzyme, and flux targets for cancer therapy
12/12/2013US20130331431 Analgesic medication
12/12/2013US20130331428 Topical compositions containing a retinoid of the oil-in-water emulsion type
12/12/2013US20130331427 Methods of stimulating cellular growth, synaptic, remodeling and consolidation of long-term memory
12/12/2013US20130331424 Antimicrobial compounds, compositions and methods of use thereof
12/12/2013US20130331423 Form of Administration of Enkephalinase Inhibitor
12/12/2013US20130331422 Methods and devices for using isoperilly alcohol
12/12/2013US20130331419 Mineralocorticoid receptor antagonists
12/12/2013US20130331418 Methods for Preventing Flea Allergy Dermatitis in Companion Animals
12/12/2013US20130331415 Compositions comprising wnt inhibitors for treating cancer
12/12/2013US20130331414 Inhibitors of Retroviral Replication
12/12/2013US20130331413 Defensin-like molecules as novel antimicrobial agents
12/12/2013US20130331412 Pharmaceutical Compositions and Administrations Thereof
12/12/2013US20130331408 Opioid Receptor Ligands and Methods of Using and Making Same
12/12/2013US20130331404 Methods and Compositions for Inhibition of Polymerase
12/12/2013US20130331403 Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio)acetic acid and uses thereof
12/12/2013US20130331402 Dosing regimen associated with long-acting injectable paliperidone esters
12/12/2013US20130331400 Method for producing indigo-plant leaf extract
12/12/2013US20130331399 Treatment of Motor and Movement Disorder Side Effects Associated with Parkinson's Disease Treatments
12/12/2013US20130331398 Modulation of ubiquitination of synaptic proteins for the treatment of neurodegenerative and psychiatric disorders
12/12/2013US20130331394 Treating schizophrenia
12/12/2013US20130331393 Therapeutic formulation and methods of treatment
12/12/2013US20130331391 Viral polymerase inhibitors
12/12/2013US20130331389 Methods and Compositions for Cardiomyocyte Replenishment by Endogenous and Progenitor Stem Cells
12/12/2013US20130331388 Combinations of Therapeutic Agents for use in the Treatment of Neurodegenerative Diseases
12/12/2013US20130331387 Heteroaryl derivatives as alpha7 nachr modulators
12/12/2013US20130331386 Methods for treating vascular leak syndrome
12/12/2013US20130331385 Compositions and methods for treating ophthalmic, otic, or nasal infections
12/12/2013US20130331384 Firmocidin, an antimicrobial molecule produced by staphylococcus epidermidis
12/12/2013US20130331383 Nitrofuran compounds for the treatment of cancer and angiogenesis
12/12/2013US20130331382 Pyridinone and Pyridazinone Derivatives
12/12/2013US20130331381 Treatment of Cancer WIth Dopamine Receptor Antagonists
12/12/2013US20130331373 Substituted bicyclic methyl azetidines as sphingosine-1 phosphate receptors modulators
12/12/2013US20130331372 Cyclic Amine Substituted Oxazolidinone CETP Inhibitor
12/12/2013US20130331369 3-Spirocyclic Piperidine Derivatives as Ghrelin Receptor Agonists
12/12/2013US20130331368 Method of treating hepatocellular carcinoma
12/12/2013US20130331366 Methods, dosing regimens and medications using anti-progestational agents for the treatment of disorders
12/12/2013US20130331365 Methods and compositions for cancer prevention and treatment
12/12/2013US20130331364 Diamide compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
12/12/2013US20130331363 Organic compounds
12/12/2013US20130331362 Ophthalmic Solution For Absorbing Ultraviolet Radiation and Method For Absorbing Ultraviolet Radiation
12/12/2013US20130331361 Dosage forms of bisphosphonates
12/12/2013US20130331360 Morpholin-4-ium 4 methoxyphenyl (morpholino) phosphinodithioate (gyy4137) as a novel vasodilator agent
12/12/2013US20130331357 Combination therapy of hsp90 inhibitory compounds with proteasome inhibitors
12/12/2013US20130331356 Proteasome Inhibitors
12/12/2013US20130331355 Cyclic boronic acid ester derivatives and therapeutic uses thereof
12/12/2013US20130331354 Method and composition utilizing larch wood extracts in animal feed
12/12/2013US20130331352 Combination of Components for the Prevention and Treatment of Frailty
12/12/2013US20130331349 Compositions and methods for modulating fxr
12/12/2013US20130331347 Treatment of Clostridium Difficile Infection in Patients Undergoing Antibiotic Therapy
12/12/2013US20130331345 Puerarin hydrates, preparation methods and uses thereof
12/12/2013US20130331334 Targeted cargo protein combination therapy
12/12/2013US20130331330 Methods of treating alzheimer's disease and other tauopathies with inhibitors of microtubule affinity regulating kinase
12/12/2013US20130331328 Small molecule inhibitors of agbl2
12/12/2013US20130331323 Glp-1 potentiators from hedychium coronarium and their applications
12/12/2013US20130331321 Perhexiline for treating chronic heart failure
12/12/2013US20130331319 Methods of delivering stable topical drug compositions
12/12/2013US20130331313 Methods and compositions for treating viral or virally-induced conditions
12/12/2013US20130331311 Synergistic Combinations of Polyene Fungicides and Non-Ribosomal Peptides and Related Methods of Use
12/12/2013US20130330429 Compositions and methods for treating depression
1 ... 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 ... 7860